DRJ continues sponsorship of Arthritis Foundation

ENCINITAS, Calif. DRJ on Wednesday announced the renewal of its proceeds sponsorship of the Arthritis Foundation, where a percentage of each purchase of the company’s Stopain external analgesic is donated to the foundation.

“We see the mission of the Arthritis Foundation as a crucial health issue,” stated Bob Miller, VP sales and marketing for DRJ Group. “Our company mission is to help chronic pain sufferers manage their pain so they can lead richer, more active lives. We believe that working in cooperation with the Arthritis Foundation will help this become a reality.”

DRJ Group will make a minimum contribution of $25,000 for the coming year.

Earlier this year, DRJ Group’s support for the Arthritis Foundation began appearing on Stopain labels. The labels read, in part, “Your purchase benefits the Arthritis Foundation. For every unit of Stopain products sold, DRJ Group Inc. will donate a portion of the proceeds to the Arthritis Foundation with a minimum contribution of $25,000 to help people take control of arthritis.”

Login or Register to post a comment.